Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, today announced the introduction of a REAP-seq (RNA expression and protein sequencing) protocol for use with the C1™ system. C1…
The British company Horizon Discovery has obtained a license to develop a CRISPR-based gene editing tool from Rutgers University, USA, with potential applications in cancer and genetic disease.
Researchers with the Dominantly Inherited Alzheimer Network (DIAN) have found that serum neurofilament light chain (Nfl) levels could aid in diagnosing and monitoring the progression of Alzheimer's disease.
Horizon Discovery has introduced a new CRISPR screening service for use on primary human T cells, which will be valuable in researching biological processes and developing new drugs.
Human kidney organoids hold promise for studying development, disease modelling and drug screening. However, the utility of stem cell-derived kidney tissues will depend on how faithfully these replicate normal fetal…
January 24th, 2019, 11:30am - 3:30pm,
NUS, MD6, Foyer 1A
BioTek Instruments introduces their next generation Epoch™ 2 Microplate Spectrophotometer; with added features that enable multiple conveniences for performing absorbance measurements. Epoch 2 now includes monochromator-based individual wavelength selection or wavelength scanning…
Jo Vandesompele at Ghent University discusses a deep dive into single-cell sequencing
Inter-sample digital processing improves sensitivity and specificity of variant calling; results superior to molecular barcoding approaches